Community Health Systems, Inc. (CYH) 股票分析

公司概述

Community Health Systems, Inc. (CYH) owns, leases, and operates general acute care hospitals throughout the United States, providing a comprehensive array of medical services including emergency room care, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic imaging, psychiatric treatment, and rehabilitation services. The company operates within the Healthcare sector and specifically targets the Medical Care Facilities industry, positioning itself as a provider of essential acute care infrastructure across the country. With a market capitalization of $443.93 million, annual revenue of $12.49 billion, and an employee base of 44,000, the organization represents a significant entity in the hospital management space. These valuation and revenue figures indicate that while the company maintains a substantial operational footprint supported by a large workforce, its market valuation reflects a specific market dynamic where revenue scale does not directly correlate with a high market cap, suggesting investors must carefully analyze the underlying asset quality and debt structure rather than relying solely on size metrics to gauge enterprise value.

财务健康

The company reported total revenue of $12.49 billion for the trailing twelve months, generating net income of $509.00 million and EBITDA of $1.45 billion. The substantial gap between the $12.49 billion in revenue and the $509.00 million in net income reveals a cost structure where operating expenses, including cost of goods sold and overhead, consume approximately 95.9% of top-line revenue before reaching the bottom line. Free cash flow stands at $395.25 million, which indicates the company's ability to generate cash from operations after capital expenditures, providing financial flexibility for debt servicing or operational maintenance despite high leverage. The gross margin is 41.7%, reflecting the pricing power and efficiency in delivering medical services, while the operating margin of 9.2% and profit margin of 4.1% demonstrate the impact of administrative costs and interest obligations on final profitability. Liquidity analysis shows a cash balance of $260.00 million against total debt of $11.04 billion, highlighting a highly leveraged balance sheet where interest coverage is critical to survival. The debt-to-equity ratio is listed as N/A, and the current ratio of 1.47 suggests adequate short-term liquidity to meet obligations due within the next year. Return on Assets stands at 5.0%, while Return on Equity is N/A; these metrics reveal that the company generates moderate returns on its asset base but faces challenges in maximizing equity returns, likely due to the capital-intensive nature of hospital operations and significant debt load.

估值评估

The trailing twelve-month P/E ratio is 0.84, whereas the forward P/E is -370.59, implying that expected earnings trajectory is currently negative or undefined, likely due to the lack of earnings growth and potential losses in forward projections. A price-to-book ratio of -0.30 indicates that the market values the company at a significant discount relative to its book value, often seen in distressed or highly leveraged entities where assets may be overvalued on the balance sheet. The price-to-sales ratio of 0.04 and an EV/EBITDA of 8.13 offer alternative valuation perspectives, suggesting the stock trades at a fraction of its sales revenue and possesses an enterprise value multiple that is low but complicated by the negative forward earnings multiple. The 52-week high is $4.47 and the 52-week low is $2.26; based on the available data points, the current trading price sits within this historical range, reflecting market volatility and sentiment regarding the company's debt restructuring or earnings stability. The beta value is 1.97, which signifies that the stock price is nearly twice as volatile as the broader market, exposing investors to heightened risk fluctuations that are typical for distressed healthcare operators facing debt pressures.

Growth & Income

Revenue growth year-over-year is -4.9%, while earnings growth year-over-year is N/A, indicating that the company is currently contracting in terms of top-line revenue generation. Since the earnings growth metric is unavailable, it is impossible to determine if earnings are growing faster or slower than revenue, but the negative revenue growth suggests a challenging operational environment or market contraction. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the company reinvests its earnings into operational growth, debt reduction, or other strategic initiatives rather than distributing cash to shareholders. The overall growth and income profile is characterized by revenue contraction, a lack of dividend income, and a reliance on operational efficiency to manage a highly leveraged balance sheet in a competitive acute care hospital landscape.